calimmune

Calimmune Initiates HIV Stem Cell Study at Two California Research Sites

(Los Angeles, CA) — The HIV gene medicines company Calimmune announced today that the first patient has begun treatment in a Phase I/II clinical trial designed to determine whether a pioneering genetic medicine approach can help to protect individuals infected with HIV from the effects of the virus. The study, ‚ÄúSafety Study of a Dual …

Calimmune Initiates HIV Stem Cell Study at Two California Research Sites Read More »

Groundbreaking Gene Therapy Study Gets The Go-Ahead By The FDA

Calimmune, a small biotechnology company, is  giving people a low dose chemo agent (as conditioning) and then infusing them with stem cells  that have been modified to inhibit the CCR5 receptor and to contain their own built-in HIV fusion inhibitor peptide, thereby blocking two sites that are essential for HIV infection.   The study is …

Groundbreaking Gene Therapy Study Gets The Go-Ahead By The FDA Read More »